Doxycycline (hyclate) (Synonyms:Doxycycline hydrochloride hemiethanolate hemihydrate; WC2031)
目录号 : KM15555 CAS No. : 24390-14-5 纯度 : 97%

Doxycycline (hyclate) (Doxycycline hydrochloride hemiethanolate hemihydrate) 是一种四环素抗生素,口服有效的,广谱的金属蛋白酶 (MMP) 抑制剂,具有抗菌活性。

规格 价格 是否有货 数量
100mg
In-stock
1g
In-stock
5g
In-stock
50g
In-stock
100g
In-stock

Other Forms of Rapamycin:

KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
生物活性

Doxycycline (hyclate) (Doxycycline hydrochloride hemiethanolate hemihydrate), an antibiotic, is an orally active and broad-spectrum metalloproteinase (MMP) inhibitor.

体外研究

Doxycycline (hyclate) (Doxycycline hydrochloride hemiethanolate hemihydrate) affects growth of glioma cells only under high concentrations.
Doxycycline (hyclate) decreases MT-CO1 protein content with concentrations of 1 µg/mL and higher in SVG cells.
Doxycycline (1 µg/mL) induce short-hairpin RNA (shRNA) expression in H23 cells.

Cell Proliferation Assay

Cell Line: LNT-229, G55, and U343 glioma cells
Concentration: 0.01, 0.1, 1, or 10 µg/mL
Incubation Time: 4 days
Result: Affected growth of glioma cells only under high concentrations.

Western Blot Analysis

Cell Line: SVG cells
Concentration: 0.01, 0.1, 1, or 10 µg/mL
Incubation Time: 24 hours
Result: Decreaseed MT-CO1 protein content with concentrations of 1 µg/mL and higher.
体内研究

Doxycycline (hyclate) (Doxycycline hydrochloride hemiethanolate hemihydrate) (oral; 200 or 800 mg/kg/day; for 3 months) reduces active MMP-9 in untreated HT mice in a dose-dependent manner.

Animal Model: 6-month-old female Heterozygous Col3a1-deficient (HT) mice
Dosage: 200 or 800 mg/kg
Administration: Oral; per day; for 3 months
Result: Reduced active MMP-9 in a dose-dependent manner.
分子式
C22H24N2O8
分子量
512.94
CAS号
24390-14-5
中文名称
多西环素盐酸盐半乙醇半水合物;强力霉素盐酸盐半乙醇半水合物
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

溶解性数据
In Vitro: 

DMSO : 240 mg/mL (467.89 mM; Need ultrasonic)

H2O : 125 mg/mL (243.69 mM; Need ultrasonic)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 1.9495 mL 9.7477 mL 19.4955 mL
5 mM 0.3899 mL 1.9495 mL 3.8991 mL
10 mM 0.1950 mL 0.9748 mL 1.9495 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: PBS

    Solubility: 20 mg/mL (38.99 mM); Clear solution; Need ultrasonic

  • 2.

    请依序添加每种溶剂: 5% DMSO    40% PEG300    5% Tween-80    50% saline

    Solubility: ≥ 3 mg/mL (5.85 mM); Clear solution

  • 3.

    请依序添加每种溶剂: 5% DMSO    95% (20% SBE-β-CD in saline)

    Solubility: ≥ 3 mg/mL (5.85 mM); Clear solution

临床试验
科研文献
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
在线客服
咨询热线
400-881-9290
关注微信公众号